Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction (Review)

被引:77
作者
Gourvas, Victor [2 ,3 ]
Dalpa, Efterpi [2 ,4 ]
Konstantinidou, Anastasia [5 ]
Vrachnis, Nikolaos [6 ]
Spandidos, Demetrios A. [2 ]
Sifakis, Stavros [1 ]
机构
[1] Univ Hosp Heraklion, Dept Obstet & Gynecol, Iraklion 71201, Crete, Greece
[2] Univ Crete, Dept Virol, Sch Med, Iraklion, Greece
[3] Gen Hosp G Genimatas, Dept Pathol, Athens, Greece
[4] Gen Hosp G Papageorgiou, Dept Pediat, Thessaloniki, Greece
[5] Univ Athens, Dept Pathol 1, Athens, Greece
[6] Univ Athens, Dept Obstet & Gynecol 2, Athens, Greece
关键词
angiogenesis; angiogenic growth factors; fetal growth restriction; placenta; pregnancy; HUMAN FETOPLACENTAL VASCULOGENESIS; DOPPLER WAVE-FORMS; MESSENGER RIBONUCLEIC-ACIDS; INTRAUTERINE GROWTH; UMBILICAL ARTERY; FACTOR VEGF; MATERNAL CIRCULATION; VASCULAR DEVELOPMENT; MOLECULAR REGULATION; REPRODUCTIVE-TRACT;
D O I
10.3892/mmr.2012.898
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The placenta is the organ that is responsible for providing the developing fetus with all the nutrients necessary for its growth and is also responsible for removing fetal waste. Placentation is a crucial process that includes angiogenesis. Angiogenesis involves not only the fetal circulation, but also placental and endometrial vascular changes. In this study, we review the literature regarding any impairment in the angiogenic process in placentas from pregnancies complicated by fetal growth restriction (FGR). Angiogenesis is regulated by a list of factors, also known as growth factors, such as the vascular endothelial growth factor (VEGF), the placental growth factor (PIGF) and the basic fibroblastic growth factor (bFGF), as well as the partial pressure of oxygen in the feto-placental vessels. Other factors, such as transcriptional factors, also play a pivotal role, controlling the above-mentioned growth factors. Alterations in these pathways have been described in cases of growth-restricted fetuses. In this review, we provide an insight into these processes and identify the most crucial factors involved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 72 条
[1]   COLOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS FLT-1 RECEPTOR IN HUMAN PLACENTA [J].
AHMED, A ;
LI, XF ;
DUNK, C ;
WHITTLE, MJ ;
RUSHTON, DI ;
ROLLASON, T .
GROWTH FACTORS, 1995, 12 (03) :235-243
[2]   Angiogenesis and intrauterine growth restriction [J].
Ahmed, A ;
Perkins, J .
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2000, 14 (06) :981-998
[3]   Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - A review [J].
Ahmed, A ;
Dunk, C ;
Ahmad, S ;
Khaliq, A .
PLACENTA, 2000, 21 :S16-S24
[4]   Vasculogenesis and angiogenesis in the IUGR placenta [J].
Arroyo, Juan A. ;
Winn, Virginia D. .
SEMINARS IN PERINATOLOGY, 2008, 32 (03) :172-177
[5]   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [J].
Asahara, T ;
Chen, DH ;
Takahashi, T ;
Fujikawa, K ;
Kearney, M ;
Magner, M ;
Yancopoulos, GD ;
Isner, JM .
CIRCULATION RESEARCH, 1998, 83 (03) :233-240
[6]   Vasculogenesis in early human placental villi:: an ultrastructural study [J].
Asan, E ;
Kaymaz, FF ;
Çakar, AN ;
Dagdeviren, A ;
Beksaç, MS .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 1999, 181 (06) :549-554
[7]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[8]  
Benirschke K., 2006, Pathology of the Human Placenta, P321
[9]  
Benjamin LE, 1998, DEVELOPMENT, V125, P1591
[10]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583